Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | NADPH dependent diflavin oxidoreductase 1 | 0.0178 | 1 | 1 |
Giardia lamblia | Hypothetical protein | 0.0158 | 0.8027 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.011 | 0.3362 | 0.3362 |
Echinococcus granulosus | methionine synthase reductase | 0.011 | 0.3362 | 0.3362 |
Leishmania major | p450 reductase, putative | 0.0178 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.0178 | 1 | 1 |
Echinococcus multilocularis | NADPH cytochrome P450 reductase | 0.0178 | 1 | 1 |
Trichomonas vaginalis | sulfite reductase, putative | 0.0178 | 1 | 1 |
Mycobacterium ulcerans | formate dehydrogenase H FdhF | 0.0178 | 1 | 0.5 |
Onchocerca volvulus | Peroxidase homolog | 0.0076 | 0 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0089 | 0.1257 | 0.5 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0178 | 1 | 0.5 |
Loa Loa (eye worm) | FAD binding domain-containing protein | 0.0178 | 1 | 1 |
Onchocerca volvulus | 0.0076 | 0 | 0.5 | |
Onchocerca volvulus | Peroxidase homolog | 0.0076 | 0 | 0.5 |
Giardia lamblia | Nitric oxide synthase, inducible | 0.0158 | 0.8027 | 0.5 |
Trypanosoma brucei | NADPH-cytochrome p450 reductase, putative | 0.0178 | 1 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0178 | 1 | 0.5 |
Trypanosoma cruzi | cytochrome P450 reductase, putative | 0.0178 | 1 | 0.5 |
Toxoplasma gondii | flavodoxin domain-containing protein | 0.0089 | 0.1257 | 0.5 |
Echinococcus granulosus | NADPH cytochrome P450 reductase | 0.0178 | 1 | 1 |
Echinococcus multilocularis | methionine synthase reductase | 0.011 | 0.3362 | 0.3362 |
Onchocerca volvulus | Chorion peroxidase homolog | 0.0076 | 0 | 0.5 |
Plasmodium vivax | NADPH-cytochrome p450 reductase, putative | 0.0178 | 1 | 1 |
Trypanosoma brucei | NADPH--cytochrome P450 reductase, putative | 0.0178 | 1 | 0.5 |
Onchocerca volvulus | 0.0076 | 0 | 0.5 | |
Plasmodium falciparum | nitric oxide synthase, putative | 0.0178 | 1 | 0.5 |
Schistosoma mansoni | cytochrome P450 reductase | 0.0178 | 1 | 1 |
Schistosoma mansoni | 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase | 0.011 | 0.3362 | 0.3362 |
Onchocerca volvulus | Peroxidasin homolog | 0.0076 | 0 | 0.5 |
Trypanosoma cruzi | NADPH-dependent FMN/FAD containing oxidoreductase, putative | 0.0178 | 1 | 0.5 |
Trypanosoma brucei | NADPH-dependent diflavin oxidoreductase 1 | 0.0178 | 1 | 0.5 |
Leishmania major | NADPH-cytochrome p450 reductase-like protein | 0.0178 | 1 | 1 |
Schistosoma mansoni | NADPH flavin oxidoreductase | 0.009 | 0.1389 | 0.1389 |
Echinococcus granulosus | NADPH dependent diflavin oxidoreductase 1 | 0.0178 | 1 | 1 |
Brugia malayi | FAD binding domain containing protein | 0.011 | 0.3362 | 0.3362 |
Trypanosoma cruzi | p450 reductase, putative | 0.0178 | 1 | 0.5 |
Onchocerca volvulus | Peroxidasin homolog | 0.0076 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0178 | 1 | 1 |
Chlamydia trachomatis | sulfite reductase | 0.011 | 0.3362 | 0.5 |
Onchocerca volvulus | Dual oxidase homolog | 0.0076 | 0 | 0.5 |
Schistosoma mansoni | diflavin oxidoreductase | 0.0089 | 0.1257 | 0.1257 |
Onchocerca volvulus | 0.0076 | 0 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.